Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Diabetes & Metabolism|November 22, 2023
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitusAlessandro Mantovani, Mario Luca Morieri, Raffaella Aldigeri, et al.
Diabetes & Metabolism|September 14, 2023
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitusAlessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, et al.
Plos Medicine|July 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) studyPiero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 DiabetesAlessandra Dei Cas, Raffaella Aldigeri, Alessandro Mantovani, et al.
Journal of the Endocrine Society|April 27, 2018
Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled TrialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trialPiero Ruggenenti, Giuseppe Lauria, Ilian Petrov Iliev, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Diabetes Care|September 30, 2020
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational StudySebastiano Bruno Solerte, Francesca D'Addio, Roberto Trevisan, et al.
Circulation|December 29, 2011
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter studyRoberto Lorusso, Sandro Gelsomino, Fabiana Lucà, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 29, 2016
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT studyMarilena Vitale, Olga Vaccaro, Maria Masulli, et al.
Pageof 11